CDKN2A and brain neoplasm: Importantly, altered expression of these three signatures was not restricted to tumours with CDKN2A/B HD, which demonstrates the additional prognostic power of our analyses. In recent years, the diagnostic classification of primary brain tumours has shifted from primarily histopathology to a more precision-oriented approach that incorporates molecular markers to optimise prognostication.